MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):95-102.
Vaccinations are recommended throughout life to prevent vaccine-preventable diseases and their sequelae. Adult vaccination coverage, however, remains low for most routinely recommended vaccines and below Healthy People 2020 targets. In October 2014, the Advisory Committee on Immunization Practices (ACIP) approved the adult immunization schedule for 2015. With the exception of influenza vaccination, which is recommended for all adults each year, other adult vaccinations are recommended for specific populations based on a person's age, health conditions, behavioral risk factors (e.g., injection drug use), occupation, travel, and other indications. To assess vaccination coverage among adults aged ≥19 years for selected vaccines, CDC analyzed data from the 2013 National Health Interview Survey (NHIS). This report highlights results of that analysis for pneumococcal, tetanus toxoid-containing (tetanus and diphtheria vaccine [Td] or tetanus and diphtheria with acellular pertussis vaccine [Tdap]), hepatitis A, hepatitis B, herpes zoster (shingles), and human papillomavirus (HPV) vaccines by selected characteristics (age, race/ethnicity,† and vaccination indication). Influenza vaccination coverage estimates for the 2013-14 influenza season have been published separately. Compared with 2012, only modest increases occurred in Tdap vaccination among adults aged ≥19 years (a 2.9 percentage point increase to 17.2%), herpes zoster vaccination among adults aged ≥60 years (a 4.1 percentage point increase to 24.2%), and HPV vaccination among males aged 19-26 years (a 3.6 percentage point increase to 5.9%); coverage among adults in the United States for the other vaccines did not improve. Racial/ethnic disparities in coverage persisted for all six vaccines and widened for Tdap and herpes zoster vaccination. Increases in vaccination coverage are needed to reduce the occurrence of vaccine-preventable diseases among adults. Awareness of the need for vaccines for adults is low among the general population, and adult patients largely rely on health care provider recommendations for vaccination. The Community Preventive Services Task Force and the National Vaccine Advisory Committee have recommended that health care providers incorporate vaccination needs assessment, recommendation, and offer of vaccination into every clinical encounter with adult patients to improve vaccination rates and to narrow the widening racial/ethnic disparities in vaccination coverage.
接种疫苗是预防可通过疫苗预防的疾病及其后遗症的有效手段。然而,大多数常规推荐疫苗的成人接种覆盖率仍然较低,且远低于“健康人民 2020 目标”。2014 年 10 月,免疫实践咨询委员会(ACIP)批准了 2015 年成人免疫计划。除了每年推荐所有成年人接种流感疫苗外,其他成人疫苗则根据个人的年龄、健康状况、行为危险因素(例如,注射吸毒)、职业、旅行和其他指征,推荐给特定人群。为评估 2013 年≥19 岁成年人的疫苗接种情况,CDC 分析了 2013 年全国健康访谈调查(NHIS)的数据。本报告重点介绍了该分析针对肺炎球菌、含破伤风类毒素(破伤风和白喉疫苗[Td]或破伤风、白喉和无细胞百日咳疫苗[Tdap])、甲型肝炎、乙型肝炎、带状疱疹(带状疱疹)和人乳头瘤病毒(HPV)疫苗接种情况的结果,分析了接种人群的特征(年龄、种族/民族,† 和接种指征)。2013-14 流感季节的流感疫苗接种覆盖率估计数已单独发布。与 2012 年相比,≥19 岁成年人的 Tdap 疫苗接种率仅略有上升(增加 2.9 个百分点,达到 17.2%),≥60 岁成年人的带状疱疹疫苗接种率上升了 4.1 个百分点(增加 4.1 个百分点,达到 24.2%),19-26 岁男性 HPV 疫苗接种率上升了 3.6 个百分点(增加 3.6 个百分点,达到 5.9%);而其他疫苗的成年人接种率没有改善。所有六种疫苗的接种率在种族/民族之间仍然存在差异,且 Tdap 和带状疱疹疫苗接种率的差异进一步扩大。为了减少成年人中可通过疫苗预防的疾病的发生,需要提高疫苗接种率。一般人群对成人疫苗的需求意识较低,而成年患者主要依靠卫生保健提供者的建议进行疫苗接种。社区预防服务工作队和国家疫苗咨询委员会建议卫生保健提供者将疫苗接种需求评估、建议和接种机会纳入与成年患者的每次临床接触中,以提高疫苗接种率,并缩小疫苗接种率在种族/民族之间日益扩大的差距。